Search Results

Emapunil 25 mg  | 99.80%

TargetMol

Emapunil is an anxiolytic drug which acts as a selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO.

More Information Supplier Page

Emapunil 2 mg  | 99.80%

TargetMol

Emapunil is an anxiolytic drug which acts as a selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO.

More Information Supplier Page

Tolvaptan 100 mg  | 97.00%

TargetMol

Tolvaptan is an orally bioavailable, selective, arginine vasopressin receptor 2 (V2, AVPR2) antagonist that can be used to treat hyponatremia.

More Information Supplier Page

Cinaciguat 1 mg  | Purity Not Available

TargetMol

Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in Clinicalal development for acute decompensated heart failure.

More Information Supplier Page

Cinaciguat 25 mg  | Purity Not Available

TargetMol

Cinaciguat (BAY 58-2667) is the first of a new class of soluble guanylate cyclase (sGC) activators in Clinicalal development for acute decompensated heart failure.

More Information Supplier Page

Defactinib 2 mg  | 99.80%

TargetMol

Defactinib is an orally bioavailable, small-molecule focal adhesion kinase (FAK) inhibitor with potential antiangiogenic and antineoplastic activities.

More Information Supplier Page

Defactinib 25 mg  | 99.80%

TargetMol

Defactinib is an orally bioavailable, small-molecule focal adhesion kinase (FAK) inhibitor with potential antiangiogenic and antineoplastic activities.

More Information Supplier Page